CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of CAD-1883 in Adults With Spinocerebellar Ataxia (Synchrony-1)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04301284
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:14.207157+00:00
Published At: 2021-04-08T00:00:00+00:00
Record Updated At: 2021-04-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Spinocerebellar Ataxias", "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia Type 3", "Spinocerebellar Ataxia Type 6", "Spinocerebellar Ataxia Type 7", "Spinocerebellar Ataxia Type 8", "Spinocerebellar Ataxia Type 10", "Spinocerebellar Ataxia Type 17", "ARCA1 - Autosomal Recessive Cerebellar Ataxia Type 1"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-04-08"
protocolSection.identificationModule.nctId: "NCT04301284"
protocolSection.identificationModule.officialTitle: "Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of CAD-1883 in Adults With Spinocerebellar Ataxia (Synchrony-1)"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.